Advertisement

Prostacyclin/Thromboxanes and Tumor Cell Metastasis

  • Kenneth V. Honn
  • James M. Onoda
  • David G. Menter
  • John D. Taylor
  • Bonnie F. Sloane
Chapter
Part of the Developments in Oncology book series (DION, volume 22)

Abstract

The ability to metastasize is a characteristic which distinguishes benign from malignant neoplasms. Metastasis can be simply defined as a loss of contiguity between a tumor cell or a clump of tumor cells and the primary tumor with successful transfer to, and growth at, a spatially separate site. The overall process can be regarded as a series of sequential events representing complex interactions between the tumor cell and the host (Figure 1).

Keywords

Platelet Aggregation Circulate Tumor Cell Lewis Lung Carcinoma Tumor Cell Adhesion Induce Platelet Aggregation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hilgard P, Beyerle L, Hohage R, Hiemeyer V and Rubier M. Eur. J. Cancer 8: 347–352, 1972.PubMedCrossRefGoogle Scholar
  2. 2.
    del Regato JA. Semin. Oncol. 4: 33–38, 1977.PubMedGoogle Scholar
  3. 3.
    Fisher ER and Fisher B. Arch. Pathol. 83: 321–324, 1967.PubMedGoogle Scholar
  4. 4.
    Fidler IJ, Gersten DM and Hart I. Adv. Cancer Res. 28: 149–250, 1978.PubMedCrossRefGoogle Scholar
  5. 5.
    Weiss L. Semin. Oncol. 4: 5–17, 1977.PubMedGoogle Scholar
  6. 6.
    Cole WH, Robert SS, Webb RS, Strehl FW and Oates GD. Ann. Surg. 161: 753–768, 1965.PubMedCrossRefGoogle Scholar
  7. 7.
    Salsbury AJ. Cancer Treat. Rev. 2: 55–72, 1975.PubMedCrossRefGoogle Scholar
  8. 8.
    Butler TP and Gullino PM. Cancer Res. 35: 512–516, 1975.PubMedGoogle Scholar
  9. 9.
    Liotta LA, Kleinerman J and Saidel GM. Cancer Res. 34: 997–1004, 1974.PubMedGoogle Scholar
  10. 10.
    Liotta LA, Kleinerman J and Saidel GM. Cancer Res. 36: 889–894, 1976.PubMedGoogle Scholar
  11. 11.
    Lotan R and Raz A. Cancer Res. 43: 2088–2093, 1983.PubMedGoogle Scholar
  12. 12.
    Glaves D. Br. J. Cancer 48: 665–673, 1983.PubMedCrossRefGoogle Scholar
  13. 13.
    Weiss L. In: Tumor Invasion and Metastasis (Ed. Liotta LA and Hart IR), Martinus Nijhoff, The Hague, pp. 81–98, 1982.Google Scholar
  14. 14.
    Weiss L. Int. J. Cancer 25: 385–392, 1980.PubMedCrossRefGoogle Scholar
  15. 15.
    Weiss L, Ward PM and Holmes JC. Int. J. Cancer 32: 79–83, 1983.PubMedCrossRefGoogle Scholar
  16. 16.
    Sato H and Suzuki M. In: Fundamental Aspects of Metastasis (Ed. Weiss L), American Elsevier:New York, pp. 311–317, 1976.Google Scholar
  17. 17.
    Hanna N. Cancer Metastasis Rev. 1: 45–64, 1982.PubMedCrossRefGoogle Scholar
  18. 18.
    Fidler IJ, Barnes Z, Fogler WE, Kirsh R, Bugelski P and Poste G. Cancer Res. 42: 496–501, 1982.PubMedGoogle Scholar
  19. 19.
    Glaves D. Invasion Metastsis 3: 160–173, 1983.Google Scholar
  20. 20.
    Irimura T, Gonzalez R and Nicolson GL. Cancer Res. 41: 3411–3418, 1981.PubMedGoogle Scholar
  21. 21.
    Irimura T and Nicolson GL. J. Supramol. Struct. Cell. Biochem. 17: 325–336, 1981.PubMedCrossRefGoogle Scholar
  22. 22.
    Takacz JS and Lampen JO. Biochem. Biophys. Res. Commun. 65: 248–257, 1975.CrossRefGoogle Scholar
  23. 23.
    Takatsuki A, Kohno K and Tamura G. Agr. Biol. Chem. 39: 2089–2091, 1975.CrossRefGoogle Scholar
  24. 24.
    Murray JC, Liotta L, Rennard SI and Martin GR. Cancer Res. 40: 347–351, 1980.PubMedGoogle Scholar
  25. 25.
    Terranova VP, Liotta LA, Russo RG and Martin GR. Cancer Res. 42: 2265–2269, 1982.PubMedGoogle Scholar
  26. 26.
    Vlodavsky I and Gospodarowicz D. Nature (London) 289: 304–306, 1981.CrossRefGoogle Scholar
  27. 27.
    Shirrmacher V, Altervogt P, Fogel M, Dennis J, Walker CA, Barz D, Schwartz R, Cheingsong-Popov R, Springer G, Robinson PJ, Nebe T, Brossmer W, Vlodavsky I, Paweletz N, Zirrmermann HP and Uhlenbrach G. Invasion Metastasis 2: 313–360, 1982.Google Scholar
  28. 28.
    Zacharski LR, Rickles FR, Henderson WG, Martin JF, Forman WB, van Eeckhout JP, Cornell CJ and Forcier RJ. Am. J. Clin. Oncol. 5: 593–609, 1982.PubMedCrossRefGoogle Scholar
  29. 29.
    Rickles FR and Edwards RL. Blood 62: 14–31, 1983.PubMedGoogle Scholar
  30. 30.
    Laghi F, DiRoberto PF, Panici PB, Margariti PA, Scribano D, Cudillo L, Villani L and Bizzi B. Tumori 69: 349–353, 1983.PubMedGoogle Scholar
  31. 31.
    Brain MC, Azzopardi JG, Baker LRI, Pinco GF, Roberts PD and Dacic JV. Br. J. Haematol. 18: 183–190, 1970.PubMedCrossRefGoogle Scholar
  32. 32.
    Donati MB and Poggi A. Br. J. Haematol. 44: 173–182, 1980.CrossRefGoogle Scholar
  33. 33.
    Harker LA and Slichter SJ. N. Eng. J. Med. 287: 999–1005, 1972.CrossRefGoogle Scholar
  34. 34.
    Gasic GJ, Boettiger D, Catalfamo JL, Gasic TB and Stewart GJ. Cancer Res. 38: 2950–2955, 1978.PubMedGoogle Scholar
  35. 35.
    Karpatkin S, Smerling A and Pearlstein E. J. Lab. Clin. Med. 96: 994–1001, 1980.PubMedGoogle Scholar
  36. 36.
    Pearlstein E, Cooper LB and Karpatkin S. J. Lab. Clin. Med. 93: 332–344, 1979.PubMedGoogle Scholar
  37. 37.
    Pearlstein E, Salk PL, Yogeeswaran G and Karpatkin S. Proc. Natl. Acad. Sci. USA 77: 4336–4339, 1980.PubMedCrossRefGoogle Scholar
  38. 38.
    Curatolo L, Colucci M, Canibini AL, Poggi A, Morasca L, Donati MB and Sejeraro N. Br. J. Cancer 40: 228–233, 1979.PubMedCrossRefGoogle Scholar
  39. 39.
    Gordon SG and Cross BA. J. Clin. Invest. 67: 1665–1671, 1981.PubMedCrossRefGoogle Scholar
  40. 40.
    Gordon SG, Franks JJ and Lewis B. Thromb. Res. 6: 127–137, 1975.PubMedCrossRefGoogle Scholar
  41. 41.
    Cavanaugh PG, Sloane BF, Bajkowski AS, Gasic TB, Gasic GJ and Honn KV. Clin. Exp. Metastasis 4: 297–307, 1983.CrossRefGoogle Scholar
  42. 42.
    Fidler IJ. Eur. J. Cancer 9: 223–227, 1973.PubMedCrossRefGoogle Scholar
  43. 43.
    Liotta LA, Kleinerman J and Saidel GM. Cancer Res. 36: 889–894, 1976.PubMedGoogle Scholar
  44. 44.
    Gorelik E, Berc WW and Herberman RB. Int. J. Cancer 33: 87–94, 1984.PubMedCrossRefGoogle Scholar
  45. 45.
    Gastpar H. J. Med. 8: 103–114, 1977PubMedGoogle Scholar
  46. 46.
    Gasic GJ, Gasic TB and Stewart CC. Proc. Natl. Acad. Sci. USA 61: 46–52, 1968.PubMedCrossRefGoogle Scholar
  47. 47.
    Sindelar WR, Tralka TS and Ketcham AS. J. Surg. Res. 18: 137–161, 1975.PubMedCrossRefGoogle Scholar
  48. 48.
    Gasic GJ, Gasic TB, Galanti N, Johnson T and Murphy S. Int. J. Cancer 11: 704–718, 1973.PubMedCrossRefGoogle Scholar
  49. 49.
    Honn KV, Cicone B and Skoff A. Science 212: 1270–1272, 1981.PubMedCrossRefGoogle Scholar
  50. 50.
    HonnKV. Clin. Exp. Metastasis 1: 103–114, 1983.PubMedCrossRefGoogle Scholar
  51. 51.
    Honn KV, Busse WD and Sloane BF. Biochem. Pharmacol. 32: 1–11, 1983.PubMedCrossRefGoogle Scholar
  52. 52.
    Honn KV, Meyer J, Neagos G, Henderson T, Westley C and Ratanatharathorn V. In: Interaction of Platelets and Tumor Cells (Ed. Jamieson GA), Alan R. Liss: New York, pp. 295–331, 1982.Google Scholar
  53. 53.
    Lione A and Bosmann HB. Cell Biol. Int. Rep. 82: 81–86, 1978.CrossRefGoogle Scholar
  54. 54.
    Maat B and Hilgard P. J. Cancer Res. Clin. Oncol. 101: 275–283, 1981.PubMedCrossRefGoogle Scholar
  55. 55.
    Colucci M, Delnini F, DeBelles Vitti G, Locati D, Poggi A, Semeraro N and Donati MB. Biochem. Pharmacol. 32: 1689–1691, 1983.PubMedCrossRefGoogle Scholar
  56. 56.
    Maniglia CA, Tudor G, Gomez J and Sartorelli AL. Cancer Lett. 16: 253–260, 1982.PubMedCrossRefGoogle Scholar
  57. 57.
    Gasic GJ, Viner ED, Budzynski AZ and Gasic GP. Cancer Res. 43: 1633–1636, 1983.PubMedGoogle Scholar
  58. 58.
    Zacharski LR, Henderson WG, Rickles FR, Forman WB, Cornell Jr. CJ, Forcier RJ, Harrower HW and Johnson RO. Cancer 44: 732–741, 1979.PubMedCrossRefGoogle Scholar
  59. 59.
    Vargaftig BB, Chignard M and Benveniste J. Biochem. Pharmacol. 30: 263 - 271, 1981.PubMedCrossRefGoogle Scholar
  60. 60.
    Hamberg M, Svensson J and Samuelsson B. Proc. Natl. Acad. Sci. USA 72: 2994–2998, 1975.PubMedCrossRefGoogle Scholar
  61. 61.
    Gorman RR. Fed. Proc. Fed. Am. Soc. Exp. Biol. 38: 83–88, 1979.Google Scholar
  62. 62.
    Heptinstall S, Bevan J, Cockbill SR, Hanley SP and Parry MJ. Thromb. Res. 29: 219–230, 1980.CrossRefGoogle Scholar
  63. 63.
    Rybicki JP and LeBreton GC. Thromb. Res. 30: 407–414, 1983.PubMedCrossRefGoogle Scholar
  64. 64.
    Mbncada S, Gryglewski RJ, Bunting S and Vane JR. Nature (London) 263: 663–665, 1976.CrossRefGoogle Scholar
  65. 65.
    Moncada S and Vane JR. In: Advances in Prostaglandin and Thromboxane Research (Eds. Samuelsson B, Ransvell PW and Paoletti R), Raven Press:New York, Vol. 6, pp. 43–60, 1980.Google Scholar
  66. 66.
    Moncada S and Vane JR. In: Biochemical Aspects of Prostaglandins and Thromboxanes (Eds. Kharasch N and Fried J), Academic Press:New York, pp. 155–177, 1977.Google Scholar
  67. 67.
    Millane KM, Dusting GJ, Salmon JA, Moncada S and Vane JR. Eur. J. Pharmacol. 54: 217–228, 1979.CrossRefGoogle Scholar
  68. 68.
    Moncada S, Gryglewski RJ, Bunting S and Vane JR. Prostaglandins 12: 715–733, 1976.PubMedCrossRefGoogle Scholar
  69. 69.
    Szczeklik A and Gryglewski RJ. In: Clinical Pharmacology of Prostacyclin (Eds. Lewis PJ and O’Grady J), Raven Press:New York, pp. 159–167, 1981.Google Scholar
  70. 70.
    Menter DG, Onoda JM, Taylor JD and Honn KV. Cancer Res. 44: 450–456, 1984.PubMedGoogle Scholar
  71. 71.
    Lerner WA, Pearlstein E, Anbrogio C and Karpatkin S. Int. J. Cancer 31: 463–469, 1983.Google Scholar
  72. 72.
    Bastida E, Ordinas A, Giardina SL and Jamieson GA. Cancer Res. 42: 4348–4352, 1982.PubMedGoogle Scholar
  73. 73.
    Pearlstein E, Ambrogio C, Gasic G and Karpatkin S. Cancer Res. 41: 4535–4539, 1981.PubMedGoogle Scholar
  74. 74.
    Bennett A, Berstock DA, Raja B and Stamford IF. Br. J. Riarmacol. 66: 415P, 1979.Google Scholar
  75. 75.
    Bennett A, DelTacca M, Stamford IF and Zebro T. Br. J. Cancer 35: 881–884, 1977.PubMedCrossRefGoogle Scholar
  76. 76.
    Feller N, Malachi T and Halbrecht I. J. Cancer Res. Clin. Oncol. 93: 275–280, 1979.PubMedCrossRefGoogle Scholar
  77. 77.
    Rolland PH, Martin PM, Jacquemier J, Rolland AM and Toga M. J. Natl. Cancer Inst. 64: 1061–1070, 1980.PubMedGoogle Scholar
  78. 78.
    Humes JL and Strausser HR. Prostaglandins 5: 183–197, 1974.CrossRefGoogle Scholar
  79. 79.
    Dowsett M, Easty GS, Powles TJ, Easty DM and Neville AM. Prostaglandins 11: 447–460, 1976.PubMedCrossRefGoogle Scholar
  80. 80.
    Tashjian AH, Voekel EF and Levine L. Prostaglandins 14: 309–317, 1977.PubMedCrossRefGoogle Scholar
  81. 81.
    Plescia DJ, Smith AN and Grinwich K. Proc. Natl. Acad. Sci. USA 72: 1848–1851, 1975.PubMedCrossRefGoogle Scholar
  82. 82.
    Powles TJ, Coonibes RC, Munro-Neville A, Ford H and Gazet JC. Lancet 2: 138, 1977.PubMedCrossRefGoogle Scholar
  83. 83.
    Maclntyre DE. In: Platelets in Biology and Pathology (Ed. Gordon JL), Elsevier/North Holland:Amsterdam, Vol. 2, pp. 211–247, 1981.Google Scholar
  84. 84.
    Honn KV, Menter D, Cavanaugh PG, Neagos G, Moilanen D, Taylor JD and Sloane BF. Acta Clin. Belg. 38: 53–67, 1983.PubMedGoogle Scholar
  85. 85.
    Fitzpatrick F, Bundy G, Gorman R, Honohan T, McGuire J and Sun F. Biochim. Biophys. Acta 573: 238–244, 1979.PubMedGoogle Scholar
  86. 86.
    Hara Y, Steiner M and Baldini MS. Cancer Res. 40: 1217–1222, 1980.PubMedGoogle Scholar
  87. 87.
    Honn KV, Menter DG, Onoda JM, Taylor JD and Sloane BF. In: Cancer Invasion and Metastasis: Biologic and Therapeutic Aspects (Eds. Nicolson GL and Milas L), Raven Press:New York, pp. 361–368, 1984.Google Scholar
  88. 88.
    Diglio CA, Grammas P, Giacomelli F and Weiner J. Lab. Invest. 46: 544–563, 1982.Google Scholar
  89. 89.
    George JW, Thoi LL and Morgan RK. Thromb. Res. 23: 69–77, 1981.PubMedCrossRefGoogle Scholar
  90. 90.
    Thompson CB, Eaton K, Princiotta SM, Rushin CA and Valleri CR. Br. J. Haematol. 50: 509–519, 1982.PubMedCrossRefGoogle Scholar
  91. 91.
    Fantone JC, Elgas LJ, Weinberger L and Varani J. Oncology 40: 421–426, 1983.PubMedCrossRefGoogle Scholar
  92. 92.
    Marcum JM, McGill M, Bastida E, Ordinas A and Jamieson GA. J. Lab. Clin. Med. 96: 1048–1053, 1980.Google Scholar
  93. 93.
    Stringfellow DA and Fitzpatrick FA. Nature (London) 282: 76–78, 1979.CrossRefGoogle Scholar
  94. 94.
    Willmott N, Malcolm A, McLeod T, Gracie A and Caiman KC. Invasion Metastasis 3: 32–51, 1983.PubMedGoogle Scholar
  95. 95.
    Salmon JA, Smith IE, Flower RS, Moncada S and Vane JR. Biochim. Biophys. Acta 523: 250–262, 1978.PubMedGoogle Scholar
  96. 96.
    Moncada S. Br. J. Pharmacol. 76: 3–31, 1982.PubMedGoogle Scholar
  97. 97.
    Szczeklik A, Nizankowski R, Skawinski S, Szczeklik J, Gluszko P and Gryglewski RJ. Lancet 1: 1111–1114.Google Scholar
  98. 98.
    Szczeklik A, Gryglewski RJ, Nizankcwski R, Musial J, Pieton R and Mruk J. Pharmacol. Res. Commun. 10: 545–556, 1978.PubMedCrossRefGoogle Scholar
  99. 99.
    Watkins WD, Peterson MB, Crone RK, Shannon DC and Levine L. Lancet 1: 1083, 1980.PubMedCrossRefGoogle Scholar
  100. 100.
    Hall RJC and Dewar HA. Lancet 1: 949, 1981.PubMedCrossRefGoogle Scholar
  101. 101.
    Morton DR and Brokow FC. J. Org. Chem. 44: 2880–2887, 1979.CrossRefGoogle Scholar
  102. 102.
    Nishiyama H and Ohno K. Tetrahed. Lett. 36: 3481–3484, 1979.CrossRefGoogle Scholar
  103. 103.
    Whittle BJR, Mancada S, Whiting F and Vane JR. Prostaglandins 19: 605–627, 1980.PubMedCrossRefGoogle Scholar
  104. 104.
    Pike JE and Bundy GL. In: Prostaglandins and Cancer (Eds. Powles TJ, Bockman RS, Honn KV and Ramwell P), Alan R. Liss:New York, pp. 67–77, 1982.Google Scholar
  105. 105.
    Seuter F, Basse WD, Mang F, Hoffmeister F, Moller E and Horstmann H. Arzneim.-Forsch./Drug Res. 29: 54–59, 1979.Google Scholar
  106. 106.
    Buchanan MR, Blajchman M and Hirsch J. Thromb. Res. 28: 157–170, 1982.PubMedCrossRefGoogle Scholar
  107. 107.
    Fiedler VB. Basic Res. Cardiol. 78: 266–280, 1983.PubMedCrossRefGoogle Scholar
  108. 108.
    Fiedler VB. Eur. J. Pharmacol. 88: 263–267, 1983.PubMedCrossRefGoogle Scholar
  109. 109.
    Philipp E, Ritter W and Patzschke K. Thromb. Res. Suppl. 4: 129–133, 1983.PubMedCrossRefGoogle Scholar
  110. 110.
    Vermylen J, Chamone DAF and Verstraete M. Lancet 1: 518–520, 1979.PubMedCrossRefGoogle Scholar
  111. 111.
    Carreras LO, Chamone DAF, Klerckx P and Vermylen J. Thromb. Res. 19: 663–670, 1980.PubMedCrossRefGoogle Scholar
  112. 112.
    Chamone DAF, van Damme B, Carreras L0 and Vermylen J. Haemostasis 10: 297–303, 1979.Google Scholar
  113. 113.
    Eling TE, Honn KV, Busse WD, Seuter F and Marnett LJ. In: Prostaglandins and Cancer (Eds. Powles TJ, Bockman RS, Honn KV and Ramwell P), Alan R. Liss:New York, pp. 783–787, 1982.Google Scholar
  114. 114.
    Marnett LJ, Siedlik PH, Ochs R, Das M, Honn KV, Warnock R, Tainer B and Eling TE. Mbl. Pharmacol., in press.Google Scholar
  115. 115.
    Fischer S, Struppler M and Weber PC. Biochem. Riarmacol. 32: 2231–2236, 1983.CrossRefGoogle Scholar
  116. 116.
    Deckmyn H, van Houtte E, Verstraete M and Vermylen J. Biochem. Pharmacol. 32: 2757–2762, 1983.PubMedCrossRefGoogle Scholar
  117. 117.
    Weksler BB, Ley LW and Jaffe EA. J. Clin. Invest. 62: 923–930, 1978.PubMedCrossRefGoogle Scholar
  118. 118.
    Brotherton AFA, Macfarlane DE and Hoak JC. Thromb. Res. 28: 637–647, 1982.PubMedCrossRefGoogle Scholar
  119. 119.
    Hemler ME, Cook HW and Lands WEM. Arch. Biochem. Biophys. 193: 340–345, 1979.PubMedCrossRefGoogle Scholar
  120. 120.
    Hemler ME and Lands WEM. J. Biol. Chem. 255: 6253–6261, 1980.PubMedGoogle Scholar
  121. 121.
    Kent RS, Diedrich SL and Whorton AR. J. Clin. Invest. 72: 455–465, 1983.PubMedCrossRefGoogle Scholar
  122. 122.
    Brotherton AFA and Hoak JC. J. Clin. Invest. 72: 1255–1261, 1983.PubMedCrossRefGoogle Scholar
  123. 123.
    Honn KV and Dunn JR. FEBS Lett. 139: 65–68, 1982.PubMedCrossRefGoogle Scholar
  124. 124.
    Busse WD, Mardin M, Grutzmann R, Dunn JR, Theodoreau M, Sloane BF and Honn KV. Fed. Proc. Fed. Am. Soc. Exp. Biol. 41: 1717, 1982.Google Scholar
  125. 125.
    Herman AG, Claeys M, Moncada S and Vane JR. Prostaglandins 18: 439–452, 1979.PubMedCrossRefGoogle Scholar
  126. 126.
    Sevilla MD and Marnett LJ. Biochem. Biophys. Res. Commun. 115: 800–806, 1983.PubMedCrossRefGoogle Scholar
  127. 127.
    Wong PY-K, Chao P H-W and McGiff JC. J. Pharmacol. Exp. Ther. 223: 757–760, 1982.PubMedGoogle Scholar
  128. 128.
    Machleidt C, Forstermann U, Anhut H and Hertting G. Eur. J. Pharmacol. 74: 19–26, 1981.PubMedCrossRefGoogle Scholar
  129. 129.
    Rosenkranz B, Fischer C, Weimer KE and Frolich JC. J. Biol. Chem. 255: 10194–10198, 1980.PubMedGoogle Scholar
  130. 130.
    Ambrus JL, Ambrus IM, Gastpar H and Williams C. J. Med. 13: 35–47, 1982.PubMedGoogle Scholar
  131. 131.
    Hall ER, Chen YC, Ho T and Wu KK. Thromb. Res. 27: 501–511, 1982.PubMedCrossRefGoogle Scholar
  132. 132.
    Bertele V, Falanga A, Roncaglioni MC, Cerletti C and de Gaetano G. Thronb. Haemostasis 47: 294, 1982.Google Scholar
  133. 133.
    Aiken JW, Shebuski RJ, Miller OV and Gorman RR. J. Pharmacol. Exp. Ther. 219: 299–308, 1981.Google Scholar
  134. 134.
    Defreyn G, Deckmyn H and Vermylen J. Thromb. Res. 26: 389–400, 1982.PubMedCrossRefGoogle Scholar
  135. 135.
    Gryglewski RJ, Bunting S, Moncada S, Flower RJ and Vane JR. Prostaglandins 12: 685–713, 1976.PubMedCrossRefGoogle Scholar
  136. 136.
    Needleman P, Wyche A and Raz A. J. Clin. Invest. 63: 345–349, 1979.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • Kenneth V. Honn
  • James M. Onoda
  • David G. Menter
  • John D. Taylor
  • Bonnie F. Sloane

There are no affiliations available

Personalised recommendations